Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CISM (Center for Innovative Systems Medicine) is a biotechnology company focused on leveraging systems biology and advanced computational modeling to accelerate drug discovery and development. The company integrates multi-omics data with proprietary algorithms to identify novel therapeutic targets and optimize lead compounds across various disease areas, including oncology and metabolic disorders. By employing a holistic systems-level approach, CISM aims to improve the precision and efficacy of treatments while reducing the time and cost associated with traditional drug development cycles. Their current pipeline consists of several early-stage programs targeting complex biological pathways that are often overlooked by conventional methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CISM.